Skip to content

Clinical observation on the treatment of male asthenospermia with acupuncture therapy of tonifying the kidney and filling the essence

Clinical observation on the treatment of male asthenospermia with acupuncture therapy of tonifying the kidney and filling the essence

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006550
Enrollment
Unknown
Registered
2022-08-30
Start date
2022-09-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthenospermia

Interventions

western medicine group:Oral Levocarnitine orally
Acupuncture combined with western medicine group:Acupuncture combined with Levocarnitine orally

Sponsors

Chengdu Xi'nan Gynecology Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
22 Years to 50 Years

Inclusion criteria

Inclusion criteria: (1) 22 years old = age = 50 years old, male; (2) Meet the Western medical diagnostic criteria of asthenospermia; (3) Accord with the standard of syndrome differentiation of kidney essence deficiency; (4) The informed consent was signed by the patient himself or by his immediate family members.

Exclusion criteria

Exclusion criteria: (1) Severe consumptive diseases or malignant tumor prone diseases affecting semen quality; (2) There were congenital diseases such as cryptorchidism, vas deferens, ejaculatory duct, epididymis, and seminal vesicle dysplasia; (3) Combined chromosomal abnormality; (4) Combined with the infection of genitourinary system such as orchitis, epididymitis, urethritis, mycoplasma and Chlamydia; (5) Suffering from serious mental disorders, such as schizophrenia, bipolar disorder, mental retardation caused by mental disorders, etc; (6) The patient has been in contact with teratogenic drugs and radiation; (7) Excessive smoking (more than 15 cigarettes per day) and excessive drinking (more than 200ml per day) were found; (8) People with bleeding tendency and prone to infection, or patients with severe allergies, skin ulcers, scars and other patients who are prohibited from acupuncture or fainting; (9) Patients who have received acupuncture treatment in recent three months; (10) Patients participating in other ongoing clinical research trials.

Design outcomes

Primary

MeasureTime frame
Forward motile sperm ratio;

Secondary

MeasureTime frame
FertiQol;Other seminal fluid indicators;Daytime sleepiness scale, insomnia severity scale;Zung Self-Rating Anxiety Sacle;Acupuncture treatment deqi meter;Zung Self-Rating Depression Scale;PSQI;Evaluation of acupuncture expectation value and clinical general impression scale;TCM symptom score;

Countries

China

Contacts

Public ContactYang Jie

Chengdu Xi'nan Gynecology Hospital

jenny_yang_jie@126.com13882296714

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026